Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 16,36116,380 of 20,252 grants

Completed TRAINING, INDIVIDUAL
Elucidating transcriptomic and functional heterogeneity of microglia in low-grade glioma and glioma-associated epilepsy.
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT Low-grade glioma (LGG) is a disease that, despite the modern standard of care, frequently recurs or progresses to high- grade glioma, such as glioblastoma...

$510.4K
USD
Completed TRAINING, INDIVIDUAL
The oncogenic functions of Neuropilin-1 in the glioblastoma tumor microenvironment
NATIONAL CANCER INSTITUTE State University New York Stony Brook United States 2021 – 2025

Abstract Glioblastoma (GB) is the most common primary tumor of the central nervous system (CNS) in adults. Despite aggressive surgery, radiation, and chemotherapy, median survival...

$364K
USD
Completed TRAINING, INDIVIDUAL
Function of Musashi-2 Methylation in Normal and Malignant Hematopoiesis
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2021 – 2024

Project Abstract Acute myeloid leukemia (AML) is an aggressive, heterogeneous disease and is characterized by the expansion of immature myeloid progenitors and the inhibition of my...

$460.4K
USD
Active NON-SBIR/STTR RPGS
PSMA’s enzymatic activity as new target for Prostate Cancer diagnosis and therapy
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

SUMMARY. The problem: Hormone therapy remains the standard treatment for prostate cancer (PC).While most patients initially respond to therapy, they will ultimately progress to let...

$7.35M
USD
Active NON-SBIR/STTR RPGS
The regulation of mutant p53 protein accumulation in cancer: molecular basis and therapeutic potential
NATIONAL CANCER INSTITUTE Rbhs -Cancer Institute of New Jersey United States 2021 – 2026

Abstract Tumor suppressor p53 is the most frequently mutated gene in human cancer, including colorectal cancer (CRC).Many tumor-associated mutant p53 (mutp53) proteins not only los...

$4.13M
USD
Completed TRAINING, INDIVIDUAL
RNA Methylation in Cancer Plasticity and Drug Resistance
NATIONAL CANCER INSTITUTE University of Southern California United States 2021 – 2025

PROJECT SUMMARY/ ABSTRACT Cancer drug resistance occurs not only by selection of genetically resistant clones, but also through phenotypic plasticity via rapid induction of transcr...

$510.4K
USD
Active NON-SBIR/STTR RPGS
Adapting and implementing evidence-based breast cancer follow-up in primary care
NATIONAL CANCER INSTITUTE Rbhs-Robert Wood Johnson Medical School United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Breast cancer survivors are a growing population and their symptom burden is significant.Despite growing evidence on specific symptoms and risk management...

$6.51M
USD
Active NON-SBIR/STTR RPGS
Biomarkers of dasatinib response and resistance in T-cell acute lymphoblastic leukemia
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2021 – 2026

Abstract Acute lymphoblastic leukemia (ALL) is the most common cancer in children, with T-cell ALL accounting for 15% of cases.T-ALL in children is associated with aggressive clini...

$6.19M
USD
Completed NON-SBIR/STTR RPGS
State-of-the-Art Synthesis of Interventions to Promote Quit Intentions and Smoking Cessation
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2024

Project Summary Most people who smoke have no intention of quitting in the next 6 months or beyond, which begs critical questions of the field of cancer prevention and control: How...

$3.2M
USD
Active NON-SBIR/STTR RPGS
Vascularized tumor explants for drug testing
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2026

Project Abstract Our understanding of cancer progression or response to therapies would benefit from easily accessible, patient- specific assays that recapitulate the biology and a...

$3.78M
USD
Completed NON-SBIR/STTR RPGS
Regulation and Function of Very Long Chain Fatty Acid Biosynthesis in Multiple Myeloma
NATIONAL CANCER INSTITUTE Wake Forest University Health Sciences United States 2021 – 2021

Multiple Myeloma (MM) is a plasma cell disorder that accounts for ~10% of all hematologic malignancies.Due to high production of IgG in endoplasmic reticulum (ER), MM cells continu...

$3.84M
USD
Active NON-SBIR/STTR RPGS
Targeting TET DNA Dioxygenases as Therapeutic Principle in Myeloid Neoplasms
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Ten Eleven Translocation (TET1, TET2 and TET3) are ?-ketoglutarate (?KG) and Fe2+ dependent DNA- dioxygenases that is a key regulator of epigenetic landsca...

$6.08M
USD
Active NON-SBIR/STTR RPGS
Persistent STAT5 signaling in polyfunctional CD4 T cells and its application in adoptive T cell therapy
NATIONAL CANCER INSTITUTE Augusta University United States 2021 – 2026

Project summary/abstract Recent advances in adoptive T-cell therapy (ACT), especially CD19-targeting chimeric antigen receptor (CAR) T-cell therapy (CD19CART), have highlighted the...

$5.28M
USD
Active NON-SBIR/STTR RPGS
Targeting CDK6 expression/activity in Ph+ and Ph1-like acute lymphoblastic leukemia (ALL)
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2021 – 2026

Abstract Philadelphia-positive acute lymhoblastic leukemia (Ph+ ALL) and Ph1-like B-ALL account for most cases of ?high-risk? adult B-ALL.Current therapies with tyrosine kinase inh...

$6.45M
USD
Active NON-SBIR/STTR RPGS
Real time colon histopathology by infrared spectroscopic imaging
NATIONAL CANCER INSTITUTE University of Illinois At Urbana-Champai... United States 2021 – 2026

Abstract Colorectal cancer (CRC) is one of the leading causes of death in the US.Active screening and early intervention in risky cancers can lead to good outcomes; however, a bott...

$4.66M
USD
Completed TRAINING, INDIVIDUAL
Germline Structural Variant Identification and Functional Determination in Childhood Cancer
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2024

Abstract A few germline pathogenic structural variants (SV) have been identified in cancer predisposition syndromes, e.g., MSH2 inversion in Lynch syndrome. The advent of short-rea...

$436.3K
USD
Completed TRAINING, INDIVIDUAL
Platelet PI3Kbeta regulation of metastasis
NATIONAL CANCER INSTITUTE Albert Einstein College of Medicine United States 2021 – 2024

Abstract Metastasis is the primary cause of morbidity and mortality among patients with solid tumors.Platelets interact with tumor cells upon their entry into the vasculature and p...

$510.4K
USD
Completed TRAINING, INDIVIDUAL
Biochemical and Mechanistic Insights into the Roles of Rad51 Paralogs in Homologous Recombination Repair
NATIONAL CANCER INSTITUTE Yale University United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT Understanding the molecular pathways disrupted in breast and ovarian cancer is vital to combating these devastating diseases.Hereditary susceptibility to c...

$460.4K
USD
Completed TRAINING, INDIVIDUAL
Regional selectivity of oncohistone H3K27M on glial development and glioma pathogenesis
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital Gr... United States 2021 – 2024

Abstract: Diffuse intrinsic pontine glioma (DIPG) is an incurable high-grade glioma arising in the brainstem primarily in younger children. DIPG 2-year survival rate is

$420.4K
USD
Completed SBIR-STTR RPGS
A Novel PET Imaging based Companion Diagnostic
NATIONAL CANCER INSTITUTE Cadenzamed, Llc United States 2021 – 2023

Abstract This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT- CA-20-012.High attrition rates?particularly at the late stage o...

$974.9K
USD